These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3687740)

  • 1. Scientific risk assessment and the regulation of human cancer risks: background and new directions.
    Barnard RC
    Am Ind Hyg Assoc J; 1987 Sep; 48(9):798-803. PubMed ID: 3687740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and decisions: advancing risk assessment.
    Abt E; Rodricks JV; Levy JI; Zeise L; Burke TA
    Risk Anal; 2010 Jul; 30(7):1028-36. PubMed ID: 20497395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogen risk assessment in the U.S. Environmental Protection Agency.
    Albert RE
    Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on risk assessment and risk management: future directions.
    Grant LD; Jarabek AM
    Toxicol Ind Health; 1990 Oct; 6(5):217-33. PubMed ID: 2274985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A toxicologist's view of cancer risk assessment.
    Rozman KK; Kerecsen L; Viluksela MK; Osterle D; Deml E; Viluksela M; Stahl BU; Greim H; Doull J
    Drug Metab Rev; 1996; 28(1-2):29-52. PubMed ID: 8744588
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification, characterization, and control of potential human carcinogens: a framework for Federal decision-making.
    Calkins DR; Dixon RL; Gerber CR; Zarin D; Omenn GS
    J Natl Cancer Inst; 1980 Jan; 64(1):169-76. PubMed ID: 6928042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE; Clewell HJ
    Clin Occup Environ Med; 2004 Aug; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The U.S. Environmental Protection Agency's inhalation RfD methodology: risk assessment for air toxics.
    Jarabek AM; Menache MG; Overton JH; Dourson ML; Miller FJ
    Toxicol Ind Health; 1990 Oct; 6(5):279-301. PubMed ID: 1670284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk characterization: A bridge to informed decision making.
    North DW
    Fundam Appl Toxicol; 1997 Oct; 39(2):81-8. PubMed ID: 9344620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discussion of the U.S. EPA methodology for determining Water Quality Standards (WQS).
    Burmaster DE; von Stackelberg KE
    Qual Assur; 1992 Jun; 1(3):192-206. PubMed ID: 1344674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for metals risk assessment.
    Fairbrother A; Wenstel R; Sappington K; Wood W
    Ecotoxicol Environ Saf; 2007 Oct; 68(2):145-227. PubMed ID: 17889701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of noncancer risk assessment approaches for use in deriving drinking water criteria.
    Gibson MC; deMonsabert SM; Orme-Zavaleta J
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):243-56. PubMed ID: 9441915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical considerations in evaluating scientific evidence of health effects of ambient ozone: a conference report.
    McClellan RO; Frampton MW; Koutrakis P; McDonnell WF; Moolgavkar S; North DW; Smith AE; Smith RL; Utell MJ
    Inhal Toxicol; 2009 Sep; 21 Suppl 2():1-36. PubMed ID: 19731972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk assessment: importance of identifying mechanisms of action.
    Bull RJ
    J Am Water Works Assoc; 1990 Oct; 82(10):57-60. PubMed ID: 11538297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.